NCAM1 and primitive neuroectodermal tumor: In the PNET case, a prevalence (70 %) of CD45 negative, CD56/CD34 positive cells was documented flanked by a population of CD45/CD4dim/CD14 positive monocytes and CD4 reactive T lymphocytes.